Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
13.44
+0.11 (0.83%)
May 23, 2025, 3:04 PM CST
SHE:002020 Revenue
Zhejiang Jingxin Pharmaceutical had revenue of 956.07M CNY in the quarter ending March 31, 2025, a decrease of -9.86%. This brings the company's revenue in the last twelve months to 4.05B, down -1.10% year-over-year. In the year 2024, Zhejiang Jingxin Pharmaceutical had annual revenue of 4.16B with 3.99% growth.
Revenue (ttm)
4.05B
Revenue Growth
-1.10%
P/S Ratio
2.74
Revenue / Employee
1.05M
Employees
3,869
Market Cap
11.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.16B | 159.72M | 3.99% |
Dec 31, 2023 | 4.00B | 218.99M | 5.79% |
Jan 1, 2023 | 3.78B | 313.30M | 9.04% |
Jan 1, 2022 | 3.47B | 208.47M | 6.40% |
Dec 31, 2020 | 3.26B | -388.61M | -10.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |